NEW YORK (GenomeWeb News) - Codon Devices successfully built a sequence-verified 35-kilobase genetic construct for Microbia's Precision Engineering Unit, the company said today.
The construct is an 80-percent synthetic gene cluster containing a biosynthetic pathway to optimize production of an active pharmaceutical ingredient.
Financial terms were not disclosed.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.
A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.
Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.
Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.